Identification and determination of impurities in drugs /
Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since thi...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Amsterdam ; New York :
Elsevier,
2000.
|
Edición: | 1st ed. |
Colección: | Progress in pharmaceutical and biomedical analysis ;
v. 4. |
Temas: | |
Acceso en línea: | Texto completo Texto completo Texto completo |
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | SCIDIR_ocn162130921 | ||
003 | OCoLC | ||
005 | 20231117014845.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 070802s2000 ne a ob 001 0 eng d | ||
040 | |a OPELS |b eng |e pn |c OPELS |d DEBSZ |d OPELS |d OCLCQ |d MERUC |d IDEBK |d OCLCQ |d OCLCE |d OCLCQ |d OCLCF |d CHVBK |d OCLCO |d YDXCP |d OCLCQ |d EBLCP |d OCLCQ |d CASUM |d OCLCO |d OCLCA |d KIJ |d D6H |d OCLCO |d OCLCA |d OCLCQ |d ADU |d LUN |d S2H |d OCLCO |d OCLCQ |d LVT |d OCLCQ |d OCLCO |d COM |d OCLCO |d OCLCQ |d OCL | ||
019 | |a 441813366 |a 645937935 |a 682037889 |a 760072726 |a 823830138 |a 823899839 |a 824091109 |a 824138967 |a 1011218187 |a 1027485173 |a 1119508891 |a 1160008851 |a 1229191374 |a 1229484515 | ||
020 | |a 9780444828996 | ||
020 | |a 0444828990 | ||
020 | |a 0080534406 |q (electronic bk.) | ||
020 | |a 9780080534404 |q (electronic bk.) | ||
020 | |a 1281058556 | ||
020 | |a 9781281058553 | ||
035 | |a (OCoLC)162130921 |z (OCoLC)441813366 |z (OCoLC)645937935 |z (OCoLC)682037889 |z (OCoLC)760072726 |z (OCoLC)823830138 |z (OCoLC)823899839 |z (OCoLC)824091109 |z (OCoLC)824138967 |z (OCoLC)1011218187 |z (OCoLC)1027485173 |z (OCoLC)1119508891 |z (OCoLC)1160008851 |z (OCoLC)1229191374 |z (OCoLC)1229484515 | ||
042 | |a dlr | ||
050 | 4 | |a RS189 |b .I29 2000eb | |
060 | 4 | |a W1 |b PR677LM v.4 2000 | |
060 | 4 | |a QV 25 |b I19 2000 | |
072 | 7 | |a TP |2 lcco | |
072 | 7 | |a PNC |2 bicssc | |
082 | 0 | 4 | |a 615/.1901 |2 22 |
084 | |a VS 5300 |2 rvk | ||
245 | 0 | 0 | |a Identification and determination of impurities in drugs / |c edited by S�andor G�or�og. |
250 | |a 1st ed. | ||
260 | |a Amsterdam ; |a New York : |b Elsevier, |c 2000. | ||
300 | |a 1 online resource (xxiii, 748 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | 1 | |a Progress in pharmaceutical and biomedical analysis ; |v v. 4 | |
520 | |a Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since this is the best way to characterise the quality and stability of bulk drugs and pharmaceutical formulations, this is the core activity in modern drug analysis. Due to the very rapid development of the analytical methodologies available for this purpose and the similarly rapid increase of the demands as regards the purity of drugs it is an important task to give a summary of the problems and the various possibilities offered by modern analytical chemistry for their solution. That is the aim of this book. The book is methodology-oriented. In the first chapter some important aspects of the background of impurity-related analytical studies (toxicological, pharmacopoeial aspects, the characterisation of the sources of impurities and the role of impurity profiling in various fields of drug research, production and therapeutic use) are summarised. Chapter two deals with related organic impurities, the strategies for impurity profiling, the use of chromatographic and related separation methods, spectroscopic, and hyphenated techniques. The subject of the third chapter is the identification and determination of residual solvents. The determination of inorganic impurities is discussed in chapter four. The special problems of degradation products as impurities are dealt with in chapter five. A separate chapter has been compiled to deal with one of the most up-to-date problems in contemporary pharmaceutical analysis, the estimation of enantiomeric purity of chiral drugs. Chapter seven is devoted to various approaches to solve the problem of polymorphic modifications as impurities. Since in the broader sense of the word the microbiological purity of drugs and drug products also belongs to this circle, the most important information from this field is summarised in chapter eight. After the mainly methodology-oriented chapters, the final one concentrates on four groups of drugs (peptides, biotechnological products, antibiotics and steroids) in order to demonstrate the use of the methods described earlier. | ||
505 | 0 | |a Chapter headings: Various Aspects of the Estimation of Impurities in Drugs. Identification, Structure Elucidation and Determination of Related Organic Impurities. Identification and Determination of Residual Solvents. Identification, Semiquantitative and Quantitative Determination of Inorganic Impurities. Degradation Products as Impurities. Determination of Enantiomeric Impurities. Estimation of Polymorphic Modifications as Impurities in Drugs. Microbiological Examination of Non-Sterile Drugs and Raw Materials. Selected Examples (Impurity Profiling of Some Groups of Drugs). | |
504 | |a Includes bibliographical references and index. | ||
588 | 0 | |a Print version record. | |
506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
650 | 0 | |a Drugs |x Analysis. | |
650 | 0 | |a Contamination (Technology) | |
650 | 0 | |a Drug adulteration. | |
650 | 0 | |a Pharmaceutical chemistry. | |
650 | 0 | |a Pharmacology. | |
650 | 2 | |a Pharmaceutical Preparations |x analysis |0 (DNLM)D004364Q000032 | |
650 | 2 | |a Chemistry, Pharmaceutical |0 (DNLM)D002626 | |
650 | 2 | |a Pharmacology |0 (DNLM)D010600 | |
650 | 6 | |a Chimie pharmaceutique. |0 (CaQQLa)201-0028674 | |
650 | 6 | |a M�edicaments |x Analyse. |0 (CaQQLa)201-0036381 | |
650 | 6 | |a Pharmacologie. |0 (CaQQLa)201-0007219 | |
650 | 6 | |a Contamination. |0 (CaQQLa)201-0038930 | |
650 | 6 | |a M�edicaments |x Falsification. |0 (CaQQLa)201-0036382 | |
650 | 7 | |a contamination. |2 aat |0 (CStmoGRI)aat300258683 | |
650 | 7 | |a pharmacology. |2 aat |0 (CStmoGRI)aat300137970 | |
650 | 7 | |a Pharmacology. |2 fast |0 (OCoLC)fst01060259 | |
650 | 7 | |a Pharmaceutical chemistry. |2 fast |0 (OCoLC)fst01060115 | |
650 | 7 | |a Contamination (Technology) |2 fast |0 (OCoLC)fst00876602 | |
650 | 7 | |a Drug adulteration. |2 fast |0 (OCoLC)fst00898652 | |
650 | 7 | |a Drugs |x Analysis. |2 fast |0 (OCoLC)fst00898769 | |
650 | 7 | |a Contamination m�edicamenteuse. |2 fmesh | |
650 | 7 | |a Pr�eparations pharmaceutiques |x analyse. |2 fmesh | |
650 | 7 | |a Arzneimittel |2 gnd |0 (DE-588)4003115-9 | |
650 | 7 | |a Pharmazeutische Analyse |2 gnd |0 (DE-588)4174139-0 | |
650 | 7 | |a Verunreinigung |2 gnd |0 (DE-588)4188107-2 | |
650 | 7 | |a M�edicaments |x Analyse. |2 ram | |
700 | 1 | |a G�or�og, S. | |
776 | 0 | 8 | |i Print version: |t Identification and determination of impurities in drugs. |b 1st ed. |d Amsterdam ; New York : Elsevier, 2000 |z 0444828990 |z 9780444828996 |w (DLC) 00039379 |w (OCoLC)43905893 |
776 | 0 | 8 | |i Online version: |t Identification and determination of impurities in drugs. |b 1st ed. |d Amsterdam ; New York : Elsevier, 2000 |w (OCoLC)760072726 |
830 | 0 | |a Progress in pharmaceutical and biomedical analysis ; |v v. 4. | |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780444828996 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/publication?issn=14643456&volume=4 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/14643456/4 |z Texto completo |